Xlife Sciences AG Key word Annual Results Xlife Sciences AG Publishes 2023 Annual Report 23Apr2024 0700 CETCEST Release of an ad hoc announcement pursuant to Art 53 LR The issuer is solely responsibl
Xlife Sciences AG / Key word: Annual Results
Xlife Sciences AG Publishes 2023 Annual Report
23-Apr-2024 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The.
Xlife Sciences AG / Key word: Mergers & Acquisitions/Takeover
VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline
29-Dec-2023 / 17:45 CET/CEST
Release of an ad hoc.
Xlife Sciences AG Key word Mergers & AcquisitionsTakeover VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline 29Dec2023 1745 CETCEST Release of an ad hoc announcement pursuant to
29.12.2023 - Xlife Sciences AG / Key word(s): Mergers & Acquisitions/Takeover VERAXA Biotech AG acquires Synimmune GmbH to expand cancer pipeline 29-Dec-2023 / 17:45 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely . Seite 1